Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysisAlexander Hamm, Edgar Dahl, Jürgen Veeck et al.|BMC Cancer|2008Cited by 247
Prediction of Progression of Non–Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective StudyMaximilian Burger, Ellen C. Zwarthoff, Madelon N.M. van der Aa et al.|European Urology|2008Cited by 178
miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancerIver Nordentoft, Lars Dyrskjøt, Karin Birkenkamp‐Demtröder et al.|BMC Medical Genomics|2012Cited by 97
Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA GenesIrene Lurkin, Ellen C. Zwarthoff, Angela A.G. van Tilborg et al.|PLoS ONE|2010Cited by 94
FGFR3 Mutations and a Normal CK20 Staining Pattern Define Low-Grade Noninvasive Urothelial Bladder TumoursJohanna M.M. van Oers, Arndt Hartmann, Peter J. Wild et al.|European Urology|2007Cited by 91